drugset / Trial / NCT07125950
SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Our study is aimed to evaluate the safety and preliminary of all-oral regimen SHR2554 combined with HRS-8080 or HRS-1358 in advanced breast cancer.
Timeline
- Start
- 2025-09-30
- Primary completion
- 2027-09-30
- Completion
- 2028-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-1358 | Unknown | — | — |
| Subject | HRS-8080 | Unknown | — | — |
| Subject | SHR2554 | Small molecule | — | — |